Rapastinel - Gate Neurosciences
Alternative Names: BV-102; GLYX-13; GLYX-13-peptide; GLYX-13-trifluoroacetate; TPPT-amide; TPPT-amide-trifluoroacetateLatest Information Update: 05 Jan 2023
At a glance
- Originator Northwestern University
- Developer Allergan; Naurex
- Class Amides; Analgesics; Antidepressants; Neuropsychotherapeutics; Oligopeptides; Small molecules
- Mechanism of Action NR2B N Methyl D Aspartate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Bipolar depression; Major depressive disorder; Neuropathic pain